{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T03:13:31Z","timestamp":1774926811073,"version":"3.50.1"},"reference-count":119,"publisher":"Informa UK Limited","issue":"10","license":[{"start":{"date-parts":[[2021,8,26]],"date-time":"2021-08-26T00:00:00Z","timestamp":1629936000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"not funded"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Clinical Immunology"],"published-print":{"date-parts":[[2021,10,3]]},"DOI":"10.1080\/1744666x.2021.1970534","type":"journal-article","created":{"date-parts":[[2021,8,19]],"date-time":"2021-08-19T07:01:04Z","timestamp":1629356464000},"page":"1059-1071","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":10,"title":["Ixekizumab: an IL-17A inhibitor for the treatment of axial Spondylarthritis"],"prefix":"10.1080","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7465-2621","authenticated-orcid":false,"given":"Stephanie R","family":"Harrison","sequence":"first","affiliation":[{"name":"NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals Trust, Leeds, UK"},{"name":"Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9683-3407","authenticated-orcid":false,"given":"Helena","family":"Marzo-Ortega","sequence":"additional","affiliation":[{"name":"NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals Trust, Leeds, UK"},{"name":"Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2021,8,26]]},"reference":[{"key":"cit0001","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2015.13"},{"key":"cit0002","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2010.79"},{"issue":"2","key":"cit0003","doi-asserted-by":"crossref","first-page":"357","DOI":"10.55563\/clinexprheumatol\/lycdc8","volume":"39","author":"Merino M","year":"2021","journal-title":"Clin Exp Rheumatol"},{"issue":"4","key":"cit0004","first-page":"S136","volume":"30","author":"Palla I","year":"2012","journal-title":"Clin Exp Rheumatol"},{"key":"cit0005","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2015.04.002"},{"key":"cit0006","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780270401"},{"key":"cit0007","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/24.3.242"},{"key":"cit0008","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2017-000586"},{"issue":"4","key":"cit0009","first-page":"iv18","volume":"59","author":"Xabier M","year":"2020","journal-title":"Rheumatology"},{"key":"cit0010","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1406182"},{"key":"cit0011","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2019.102429"},{"key":"cit0012","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2019-215356"},{"key":"cit0013","doi-asserted-by":"publisher","DOI":"10.1007\/s11739-011-0517-7"},{"key":"cit0014","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-018-8702-3"},{"key":"cit0015","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-019-0243-5"},{"key":"cit0016","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejr.2015.01.001"},{"key":"cit0017","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2016-000284"},{"key":"cit0018","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.2155"},{"key":"cit0019","doi-asserted-by":"publisher","DOI":"10.2217\/imt.12.134"},{"key":"cit0020","first-page":"0","author":"Coates LC","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"cit0021","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kez684"},{"key":"cit0022","doi-asserted-by":"publisher","DOI":"10.1007\/s40744-020-00250-3"},{"key":"cit0023","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-020-02388-5"},{"issue":"4","key":"cit0024","first-page":"566","volume":"37","author":"Kavanaugh A","year":"2019","journal-title":"Clin Exp Rheumatol"},{"key":"cit0025","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1512711"},{"key":"cit0026","doi-asserted-by":"publisher","DOI":"10.1007\/s13555-016-0102-0"},{"key":"cit0027","doi-asserted-by":"publisher","DOI":"10.1038\/ng.873"},{"key":"cit0028","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2667"},{"key":"cit0029","doi-asserted-by":"publisher","DOI":"10.1002\/art.37936"},{"key":"cit0030","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2007.17"},{"key":"cit0031","doi-asserted-by":"publisher","DOI":"10.1002\/art.24763"},{"key":"cit0032","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1002653"},{"key":"cit0033","doi-asserted-by":"publisher","DOI":"10.1002\/art.38638"},{"key":"cit0034","doi-asserted-by":"publisher","DOI":"10.1002\/art.34423"},{"key":"cit0035","doi-asserted-by":"publisher","DOI":"10.1186\/1480-9222-14-10"},{"key":"cit0036","doi-asserted-by":"publisher","DOI":"10.3109\/08916934.2014.976630"},{"key":"cit0037","doi-asserted-by":"publisher","DOI":"10.1002\/art.38773"},{"key":"cit0038","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-06933-4"},{"key":"cit0039","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2817"},{"key":"cit0040","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.081121"},{"key":"cit0041","doi-asserted-by":"publisher","DOI":"10.1002\/art.23755"},{"key":"cit0042","doi-asserted-by":"publisher","DOI":"10.1002\/art.34600"},{"key":"cit0043","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0193485"},{"key":"cit0044","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(200106)44:6<1293::AID-ART221>3.0.CO;2-T"},{"key":"cit0045","doi-asserted-by":"publisher","DOI":"10.1186\/ar2936"},{"key":"cit0046","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20061775"},{"key":"cit0047","doi-asserted-by":"publisher","DOI":"10.1172\/JCI5703"},{"key":"cit0048","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2018.02.164"},{"key":"cit0049","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/5950395"},{"key":"cit0050","unstructured":"National Institute of Clinical Excellence (NICE). TNF-alpha inhibitors for ankylosing spondylitis and non-radiographic axial spondyloarthritis [TA383] [Internet]. London, UK. 2016 [cited 2020 Nov 14]. Available from: https:\/\/www.nice.org.uk\/guidance\/ta383."},{"key":"cit0051","unstructured":"National Institute of Clinical Excellence (NICE). TNF-inhibitors for ankylosing spondylitis and non-radiographic axial spondyloarthritis [Internet]. London, UK. 2016 [cited 2021 May 1]. Available from: https:\/\/www.nice.org.uk\/guidance\/ta383\/resources\/tnfalpha-inhibitors-for-ankylosing-spondylitis-and-nonradiographic-axial-spondyloarthritis-pdf-2984675907013National Institute of Clinical Excellence (NICE). TNF-inhibitors for ankylosing spondylitis and non-radiographic axial spondyloarthritis [Internet]. London, UK. 2016 [cited 2021 May 1]. Available from: https:\/\/www.nice.org.uk\/guidance\/ta383\/resources\/tnfalpha-inhibitors-for-ankylosing-spondylitis-and-nonradiographic-axial-spondyloarthritis-pdf-2984675907013National Institute of Clinical Excellence (NICE). TNF-inhibitors for ankylosing spondylitis and non-radiographic axial spondyloarthritis [Internet]. London, UK. 2016 [cited 2021 May 1]. Available from: https:\/\/www.nice.org.uk\/guidance\/ta383\/resources\/tnfalpha-inhibitors-for-ankylosing-spondylitis-and-nonradiographic-axial-spondyloarthritis-pdf-2984675907013"},{"key":"cit0052","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2005.041137"},{"key":"cit0053","doi-asserted-by":"publisher","DOI":"10.1002\/art.39298"},{"key":"cit0054","doi-asserted-by":"publisher","DOI":"10.1002\/art.21913"},{"key":"cit0055","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-204231"},{"key":"cit0056","doi-asserted-by":"publisher","DOI":"10.1002\/art.11325"},{"key":"cit0057","doi-asserted-by":"publisher","DOI":"10.1002\/art.23969"},{"key":"cit0058","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)08215-6"},{"key":"cit0059","doi-asserted-by":"publisher","DOI":"10.1136\/ard.62.9.817"},{"key":"cit0060","first-page":"193","volume":"7","author":"Moorken E","year":"2016","journal-title":"Front Pharmacol"},{"key":"cit0061","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2017-211937"},{"key":"cit0062","volume-title":"Fifth stakeholder conference on biosimilar medicines","author":"European Commission","year":"2019"},{"key":"cit0063","doi-asserted-by":"publisher","DOI":"10.4103\/0973-3698.284744"},{"key":"cit0064","doi-asserted-by":"publisher","DOI":"10.1007\/s40801-016-0093-2"},{"key":"cit0065","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2019-216841"},{"key":"cit0066","doi-asserted-by":"publisher","DOI":"10.1080\/14712598.2018.1468884"},{"key":"cit0067","doi-asserted-by":"publisher","DOI":"10.1093\/rap\/rkz012"},{"key":"cit0068","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-016-0969-2"},{"key":"cit0069","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-020-02288-8"},{"key":"cit0070","doi-asserted-by":"publisher","DOI":"10.1186\/ar3054"},{"key":"cit0071","unstructured":"Stewart J. Cosentyx FDA Approval History [Internet]. Auckland, New Zealand. 2021 [cited 2021 Jun 29]. Available from: Cosentyx FDA Approval History."},{"key":"cit0072","unstructured":"Stewart J. Taltz FDA approval history [Internet]. Auckland, New Zealand. 2020 [cited 2020 Jun 29]. Available from: https:\/\/www.drugs.com\/history\/taltz.html"},{"key":"cit0073","unstructured":"European Medicines Agency. Cosentyx [Internet]. Amsterdam, Netherlands. 2021 [cited 2021 Jun 29]. Available from: https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/cosentyx"},{"key":"cit0074","unstructured":"European Medicines Agency. Taltz [Internet]. Amsterdam, Netherlands. 2021 [cited 2021 Jun 29]. Available from: https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/taltz#assessment-history-section"},{"key":"cit0075","unstructured":"National Institute of Clinical Excellence (NICE). Secukinumab for treating non-radiographic axial spondyloarthritis [Internet]. London, UK. 2021 [cited 2021 Jul 5]. Available from: https:\/\/www.nice.org.uk\/consultations\/1275\/3\/recommendations."},{"key":"cit0076","unstructured":"National Institute of Clinical Excellence (NICE). Final appraisal document - Ixekizumab for treating axial spondyloarthritis [Internet]. London, UK. 2021 [cited 2021 Jun 29]. Available from: https:\/\/www.nice.org.uk\/guidance\/gid-ta10458\/documents\/final-appraisal-determination-document."},{"key":"cit0077","unstructured":"Eli Lily and Company. About Taltz [Internet]. Indianapolis, USA. 2021 [cited 2021 Jun 29]. Available from: https:\/\/www.taltz.com\/hcp\/moa-il17a-igg4"},{"key":"cit0078","unstructured":"DrugbankOnline. Ixekizumab [Internet]. Alberta, Canada. 2021 [cited 2021 Jun 29]. Available from: https:\/\/go.drugbank.com\/drugs\/DB11569"},{"key":"cit0079","unstructured":"Eli Lilly and Company Limited. Taltz 80 mg solution for injection in pre-filled syringe [Internet]. Basingstoke,UK. 2021 [cited 2021 Apr 20]. Available from: https:\/\/www.medicines.org.uk\/emc\/product\/8199\/smpc#gref."},{"key":"cit0080","unstructured":"European Medicines Agency. Assessment report Taltz [Internet]. Amsterdam, Netherlands. 2020 [cited 2021 Jun 29]. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/variation-report\/taltz-h-c-003943-ii-0030-epar-assessment-report-variation_en.pdf"},{"key":"cit0081","unstructured":"British National Formulary. Ixekizumab [Internet]. London, UK. 2021 [cited 2021 May 1]. Available from: https:\/\/bnf.nice.org.uk\/drug\/ixekizumab.html"},{"key":"cit0082","doi-asserted-by":"publisher","DOI":"10.1002\/art.41477"},{"key":"cit0083","doi-asserted-by":"publisher","DOI":"10.1007\/s40744-018-0123-5"},{"key":"cit0084","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2017-000592"},{"key":"cit0085","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1505066"},{"key":"cit0086","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)32971-X"},{"key":"cit0087","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)31946-9"},{"key":"cit0088","doi-asserted-by":"publisher","DOI":"10.1002\/art.40753"},{"key":"cit0089","unstructured":"UCB Biopharma S.P.R.L. A study to test the efficacy and safety of bimekizumab and certolizumab Pegol in patients with active ankylosing spondylitis [Internet]. Bethesda, USA. 2020 [cited 2021 May 1]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03215277"},{"key":"cit0090","unstructured":"UCB Biopharma S.P.R.L. A study to evaluate the efficacy and safety of bimekizumab in subjects with active nonradiographic axial spondyloarthritis (BE MOBILE 1) [Internet]. Bethesda, USA. 2021 [cited 2021 May 3]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03928704"},{"key":"cit0091","unstructured":"UCB Biopharma S.P.R.L. A study to evaluate the efficacy and safety of different doses of bimekizumab in subjects with active ankylosing spondylitis (BE AGILE) [Internet]. Bethesda, USA. 2020 [cited 2021 May 1]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02963506"},{"key":"cit0092","unstructured":"UCB Biopharma S.P.R.L. A study to evaluate the long-term safety, tolerability and efficacy of bimekizumab in subjects with active axial spondyloarthritis including ankylosing spondylitis and nonradiographic axial spondyloarthritis (BE MOVING) [Internet]. Bethesda, USA. 2020 [cited 2021 Apr 21]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04436640"},{"key":"cit0093","unstructured":"UCB Biopharma S.P.R.L. A study to evaluate the efficacy and safety of bimekizumab in subjects with active nonradiographic axial spondyloarthritis (BE MOBILE 1) [Internet]. Bethsada, USA. [cited 2021 May 3]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03928704"},{"key":"cit0094","unstructured":"Kyowa Kirin Co. Ltd. A study of KHK4827 in subjects with axial spondyloarthritis (axSpA) [Internet]. Bethesda, USA. 2020 [cited 2021 May 1]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02985983"},{"key":"cit0095","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2019-216118"},{"issue":"6","key":"cit0096","first-page":"e75","volume":"79","author":"Dougados M","year":"202","journal-title":"Ann Rheum Dis"},{"key":"cit0097","unstructured":"European Medicine Agency. Assessment report Taltz [Internet]. Amsterdam, Netherlands. 2020 [Cited 2021 Jul 01]. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/variation-report\/taltz-h-c-003943-ii-0030-epar-assessment-report-variation_en.pdf"},{"key":"cit0098","doi-asserted-by":"publisher","DOI":"10.1002\/acr.24482"},{"key":"cit0099","unstructured":"Eli Lilly and Company. A long term extension study of ixekizumab (LY2439821) in participants with axial spondyloarthritis [Internet]. Bethesda, USA. 2021 [cited 2021 Jun 29]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/results\/NCT03129100"},{"key":"cit0100","doi-asserted-by":"publisher","DOI":"10.1002\/art.38617"},{"key":"cit0101","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-217927"},{"key":"cit0102","doi-asserted-by":"publisher","DOI":"10.1111\/jcpt.13416"},{"issue":"12","key":"cit0103","first-page":"3834","volume":"59","author":"Genovese MC","year":"2020","journal-title":"Revmatol"},{"key":"cit0104","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2011-301668"},{"key":"cit0105","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0233781"},{"key":"cit0106","doi-asserted-by":"publisher","DOI":"10.1080\/03007995.2019.1620713"},{"issue":"10","key":"cit0107","volume":"72","author":"Magrey M","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"cit0108","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keaa543"},{"key":"cit0109","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(200108)44:8<1876::AID-ART326>3.0.CO;2-F"},{"key":"cit0110","doi-asserted-by":"publisher","DOI":"10.1002\/art.24024"},{"key":"cit0111","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kex081"},{"key":"cit0112","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-018-1707-8"},{"key":"cit0113","doi-asserted-by":"publisher","DOI":"10.1097\/CM9.0000000000001099"},{"key":"cit0114","doi-asserted-by":"publisher","DOI":"10.1186\/ar2855"},{"key":"cit0115","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/826316"},{"key":"cit0116","doi-asserted-by":"publisher","DOI":"10.1186\/ar3309"},{"key":"cit0117","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-020-0450-0"},{"key":"cit0118","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0809242105"},{"key":"cit0119","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kex220"}],"container-title":["Expert Review of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/1744666X.2021.1970534","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,7]],"date-time":"2023-01-07T16:27:37Z","timestamp":1673108857000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/1744666X.2021.1970534"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,26]]},"references-count":119,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,10,3]]}},"alternative-id":["10.1080\/1744666X.2021.1970534"],"URL":"https:\/\/doi.org\/10.1080\/1744666x.2021.1970534","relation":{},"ISSN":["1744-666X","1744-8409"],"issn-type":[{"value":"1744-666X","type":"print"},{"value":"1744-8409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,26]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierm20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierm20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2021-06-03","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-08-17","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-08-26","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}